Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

Keith Shaw: Counterfeiting is no longer just about luxury goods or fake currency. It’s now infiltrating areas like pharmaceuticals, cosmetics, and even automotive and aviation parts. New technologies ...

Drugmaker Sai Parenterals, analytics startup Linkrunner, and software-as-a-service (SaaS) platform Monetize360 have ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, outlines how the company is ...

Katalyze AI, an advanced AI company revolutionizing the biomanufacturing process, today announced the launch of ...

Teva Pharmaceutical (NYSE: TEVA) is one of the most undervalued large cap stocks to buy according to analysts. On June 24, ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

The pharmaceutical air logistics sector is entering a new phase with the official launch of Healthc’Air, a pioneering entity ...